Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Roldán

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 20, 2019
Security profile of direct anticoagulants. Preferred use in atrial fibrillationInmaculada Roldán Rabadán, María Alonso de Leciñana, Raquel Barba Martín, et al.
Medicina Clinica|December 18, 2008
[Clinical characteristics, epidemiology and prognosis of acute coronary syndrome without ST-segment elevation and angiographically normal coronary arteries]Miguel Angel Navas Lobato, Roberto Martín Reyes, Rafael Peinado Peinado, et al.
International Journal of Cardiology|August 18, 2016
Oral anticoagulation in octogenarians with atrial fibrillationGonzález Saldivar Hugo, Lourdes M Figueiras-Graillet, Manuel Anguita, et al.
Clinical Cardiology|May 13, 2015
Quality of Anticoagulation With Vitamin K AntagonistsVicente Bertomeu-González, Manuel Anguita, José Moreno-Arribas, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 1, 2015
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA StudyJosé Moreno-Arribas, Vicente Bertomeu-González, Manuel Anguita-Sanchez, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 30, 2017
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA RegistryMartín Ruiz Ortiz, Javier Muñiz, Paula Raña Míguez, et al.
Revista Espanola De Cardiologia (English Ed.)|June 22, 2015
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA RegistryInmaculada Roldán Rabadán, Manuel Anguita Sánchez, Francisco Marín, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 2, 2020
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA StudyMartín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, et al.
Revista Espanola De Cardiologia (English Ed.)|June 5, 2019
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA studyManuel Anguita Sánchez, Vicente Bertomeu Martínez, Martín Ruiz Ortiz, et al.
Medicina Clinica|June 4, 2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registriesJosé Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 20, 2019
Security profile of direct anticoagulants. Preferred use in atrial fibrillationInmaculada Roldán Rabadán, María Alonso de Leciñana, Raquel Barba Martín, et al.
Medicina Clinica|December 18, 2008
[Clinical characteristics, epidemiology and prognosis of acute coronary syndrome without ST-segment elevation and angiographically normal coronary arteries]Miguel Angel Navas Lobato, Roberto Martín Reyes, Rafael Peinado Peinado, et al.
International Journal of Cardiology|August 18, 2016
Oral anticoagulation in octogenarians with atrial fibrillationGonzález Saldivar Hugo, Lourdes M Figueiras-Graillet, Manuel Anguita, et al.
Clinical Cardiology|May 13, 2015
Quality of Anticoagulation With Vitamin K AntagonistsVicente Bertomeu-González, Manuel Anguita, José Moreno-Arribas, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 1, 2015
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA StudyJosé Moreno-Arribas, Vicente Bertomeu-González, Manuel Anguita-Sanchez, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 30, 2017
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA RegistryMartín Ruiz Ortiz, Javier Muñiz, Paula Raña Míguez, et al.
Revista Espanola De Cardiologia (English Ed.)|June 22, 2015
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA RegistryInmaculada Roldán Rabadán, Manuel Anguita Sánchez, Francisco Marín, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 2, 2020
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA StudyMartín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, et al.
Revista Espanola De Cardiologia (English Ed.)|June 5, 2019
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA studyManuel Anguita Sánchez, Vicente Bertomeu Martínez, Martín Ruiz Ortiz, et al.
Medicina Clinica|June 4, 2025
Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registriesJosé Miguel Rivera-Caravaca, Danilo Menichelli, Daniele Pastori, et al.
Pageof 4